| #377 |
Claire Holland |
Glaxo Group Limited |
1 |
| #377 |
Duc Long Nguyen |
Koniniklijke Philips N.V. |
1 |
| #377 |
Dhiraj Gunda |
— |
1 |
| #377 |
Nicholas E. LEVY |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #377 |
Rosalind Toth |
Dow Global Technologies |
1 |
| #377 |
Olga Monastyrskaya |
Oracle |
1 |
| #377 |
Jessica Rachel MOLEK |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #377 |
Andre C. DUMETZ |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #377 |
Leandro Luiz Dos Santos |
Incyte |
1 |
| #377 |
Manish Pandya |
— |
1 |
| #377 |
Anjani Ganti |
Rutgers, The State University Of New Jersey |
1 |
| #377 |
Robert Borbo Kargbo |
— |
1 |
| #377 |
Ivan Avila |
Johnson & Johnson |
1 |
| #377 |
Ashwin Pasumarti |
Battelle Memorial Institute |
1 |
| #377 |
Zakiuddin Shehzan Ayub Mohammed |
Cesium Gs |
1 |
| #377 |
Dara Lisa Dinner |
Glaxosmithkline Consumer Healthcare Holdings (Us) |
1 |
| #377 |
Jennifer Schranz |
Takeda Pharmaceutical Company Limited |
1 |
| #377 |
Donna Yosmanovich |
— |
1 |
| #377 |
Sokreine Suon |
Merck |
1 |
| #377 |
Brian T. Wood |
Arkema |
1 |
| #377 |
Jyotsna Samhita Gokavarapu |
Schweitzer Engineering Laboratories |
1 |
| #377 |
Conrad Cowan |
Trevena |
1 |
| #377 |
Michael Koblish |
Trevena |
1 |
| #377 |
Sorina MORAR-MITRICA |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #377 |
Yu Chang Ou |
Accenture Global Solutions Limited |
1 |
| #377 |
Joel David KARPIAK |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #377 |
Keerthi Samhita Vempatti Venkatanaga |
Accenture Global Solutions Limited |
1 |
| #377 |
Chelsea Ariane Huff |
Glaxosmithkline Intellectual Property Development Limited |
1 |